{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T01:53:17Z","timestamp":1769219597637,"version":"3.49.0"},"reference-count":69,"publisher":"Japanese Society of Allergology","issue":"4","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T00:00:00Z","timestamp":1430265600000},"content-version":"vor","delay-in-days":1944,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2010]]},"DOI":"10.2332\/allergolint.10-rai-0260","type":"journal-article","created":{"date-parts":[[2010,12,13]],"date-time":"2010-12-13T01:12:44Z","timestamp":1292202764000},"page":"333-343","source":"Crossref","is-referenced-by-count":65,"title":["Recognition of Immune Reconstitution Syndrome Necessary for Better Management of Patients with Severe Drug Eruptions and Those under Immunosuppressive Therapy"],"prefix":"10.2332","volume":"59","author":[{"given":"Tetsuo","family":"Shiohara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maiko","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Mizukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Kano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1154","reference":[{"key":"10.2332\/allergolint.10-RAI-0260_bb0005","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/archderm.134.9.1108","article-title":"Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome","volume":"134","author":"Suzuki","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0010","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12016-007-8010-9","article-title":"A complex interaction between drug allergy and viral infection","volume":"33","author":"Shiohara","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0015","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2230.1997.tb01038.x","article-title":"Increased drug reactions in HIV-1-positive patients: a possible explanation based on patterns of immune dysregulation seem in HIV-1 disease","volume":"22","author":"Smith","year":"1997","journal-title":"Clin Exp Dermatol"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0020","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cncr.22738","article-title":"Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: Proof of principle, description, and clinical and research implications","volume":"110","author":"Miceli","year":"2007","journal-title":"Cancer"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0025","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1086\/527390","article-title":"Adjuvant corticosteroid therapy for chronic disseminated candidiasis","volume":"46","author":"Legrand","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0030","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1086\/427941","article-title":"Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis","volume":"40","author":"Garcia Vidal","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0035","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1086\/522993","article-title":"A patient with de novo tuberculosis during antitumor necrosis factor-alpha therapy illustrating diagnostic pitfalls and paradoxical response to treatment","volume":"45","author":"Arend","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0040","first-page":"1057","article-title":"Immune reconstitution to Mycobacterium tuberculosis after discontinuing infliximab","volume":"9","author":"Belknap","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0045","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1086\/313809","article-title":"Immunorestitution disease involving the innate and adaptive response","volume":"30","author":"Cheng","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0050","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/QAI.0b013e3181594c8c","article-title":"Immune reconstitution inflammatory syndrome: risk factors and treatment implications","volume":"46","author":"Manabe","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0055","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1002\/eji.200535385","article-title":"Reconstitution of the lymphocyte compartment after lymphocyte depletion: A key issue in clinical immunology","volume":"35","author":"Hakim","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0060","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/S0140-6736(97)10291-4","article-title":"Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease","volume":"351","author":"Li","year":"1998","journal-title":"Lancet"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0065","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1086\/315013","article-title":"Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults","volume":"180","author":"Notermans","year":"1999","journal-title":"J Infect Dis"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0070","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1086\/383034","article-title":"Immune reconstitution in HIV-infected patients","volume":"38","author":"Hirsch","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0075","first-page":"669","article-title":"Cutaneous intolerance to tattoos in a patient with human immunodeficiency virus: a manifestation of the immune restoration syndrome","volume":"137","author":"Silvestre","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0080","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1200\/JCO.2005.14.597","article-title":"Immune reconstitution inflammatory syndrome associated with Kaposi\u2019s sarcoma","volume":"23","author":"Bower","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0085","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0140-6736(96)90212-3","article-title":"Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus","volume":"347","author":"Vento","year":"1996","journal-title":"Lancet"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0090","first-page":"648","article-title":"Sarcoid-like granulomatous disease following etanercept treatment for RA","volume":"34","author":"Kudrin","year":"2007","journal-title":"J Rheumatol"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0095","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s10067-007-0594-1","article-title":"Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients","volume":"26","author":"Verschueren","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0100","first-page":"2495","article-title":"Sarcoidosis-like reaction related to propionibacterium acnes and immune restoration syndrome in HIV infection","volume":"34","author":"EI Karoui","year":"2007","journal-title":"J Rheumatol"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0105","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1378\/chest.119.3.978","article-title":"Recurrent pulmonary sarcoidosis in HIV-infected patients receiving highly active antiretroviral therapy","volume":"119","author":"Lenner","year":"2001","journal-title":"Chest"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jama.280.1.72","article-title":"Recovery of the immune system with antiretroviral therapy: the end of opportunism?","volume":"280","author":"Powderly","year":"1998","journal-title":"JAMA"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0115","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00005792-200205000-00005","article-title":"Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy","volume":"81","author":"Shelburne","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0120","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00130832-200308000-00004","article-title":"Human herpes-virus 6 and drug allergy","volume":"3","author":"Hashimoto","year":"2003","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0125","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1365-2133.2007.07807.x","article-title":"The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations","volume":"156","author":"Shiohara","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2332\/allergolint.55.1","article-title":"Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses","volume":"55","author":"Shiohara","year":"2006","journal-title":"Allergol Int"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0135","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.iac.2009.04.007","article-title":"The variable clinical picture of drug- induced hypersensitivity syndrome (DIHS)\/drug rash with eosinophilia and systemic symptoms (DRESS) in relation to the eliciting drug","volume":"28","author":"Kano","year":"2009","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0140","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.mcna.2010.03.004","article-title":"Visceral involvements and long-term sequelae in drug-induced hypersensitivity syndrome","volume":"94","author":"Kano","year":"2010","journal-title":"Med Clin North Am"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0145","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2133.2006.07238.x","article-title":"Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease","volume":"155","author":"Kano","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0150","series-title":"Drug Hypersensitivity","first-page":"251","article-title":"Drug-induced hypersensitivity syndrome","author":"Shiohara","year":"2007"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0155","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/archderm.140.2.183","article-title":"Association between anticonvulsant hypersensitivity syndrome and human herpes-virus 6 reactivation and hypogammaglobulinenia","volume":"140","author":"Kano","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0160","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1468-1293.2005.00277.x","article-title":"The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy","volume":"6","author":"Jevtovic","year":"2005","journal-title":"HIV Med"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0165","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/infdis\/166.5.1153","article-title":"Herpes zoster and human immunodeficiency virus infection","volume":"166","author":"Buchbinder","year":"1992","journal-title":"J Infect Dis"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0170","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.det.2006.06.007","article-title":"Dermatologic manifestations of the immune reconstitution inflammatory syndrome","volume":"24","author":"Leohloenya","year":"2006","journal-title":"Dermatol Clin"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0175","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1086\/515019","article-title":"High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors","volume":"27","author":"Martinez","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0180","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jaci.2004.01.768","article-title":"Varicella zoster as a manifestation of immune restoration disease in HIV-infected children","volume":"113","author":"Tangsinmankong","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0185","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0002-9343(01)00703-3","article-title":"Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with human immunodeficiency virus type-1 infection","volume":"110","author":"Domingo","year":"2001","journal-title":"Am J Med"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0190","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/00002030-200306130-00025","article-title":"Plasma IL-6 as a marker of mycobacterial immune restoration disease in HIV-1 infection","volume":"17","author":"Morlese","year":"2003","journal-title":"AIDS"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0195","doi-asserted-by":"crossref","first-page":"11425","DOI":"10.1128\/JVI.76.22.11425-11433.2002","article-title":"Tropism of varicella-zoster virus fro human tonsillar CD4 (+) T lymphocytes that express activation, memory, and skin homing markers","volume":"76","author":"Ku","year":"2002","journal-title":"J Virol"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0200","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1084\/jem.20040634","article-title":"Varicella-zoster virus transfer to skin by T cells and modulation of viral replication by epidermal cell interferon-alpha","volume":"200","author":"Ku","year":"2004","journal-title":"J Exp Med"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0205","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1086\/427995","article-title":"and Uganda-Case Western Research Collaboration. Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda","volume":"191","author":"Mayanja-Kizza","year":"2005","journal-title":"J Infect Dis"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0210","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/510623","article-title":"Reconstitution of herpes simplex virus-specific T cell immunity in HIV-infected patients receiving highly active antiretroviral therapy","volume":"195","author":"Ramaswamy","year":"2007","journal-title":"J Infect Dis"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0215","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1086\/499356","article-title":"Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort","volume":"42","author":"Ratnam","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0220","first-page":"107","article-title":"Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy","volume":"1","author":"French","year":"2000","journal-title":"HIVMed"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0225","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s10875-006-9008-4","article-title":"Interferon-gamma responses to Candida recover slowly or remain low in immunodeficient HIV patients responding to ART","volume":"26","author":"Burgess","year":"2006","journal-title":"J Clin Immunol"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0230","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/00015550310007481","article-title":"Human herpes virus 6 encephalitis in allopurinol-induced hypersensitivity syndrome","volume":"83","author":"Masaki","year":"2003","journal-title":"Acta Derm Venereol"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0235","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2230.2007.02645.x","article-title":"Syndrome of inappropriate secretion of antidiuretic hormone associated with limbic encephalitis in a patient with drug- induced hypersensitivity syndrome","volume":"33","author":"Sakuma","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0240","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/sj.bmt.1703596","article-title":"Human herpesvirus-6 encephalitis after unrelated umbilical cord blood transplant in children","volume":"29","author":"Chik","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0245","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1053\/jinf.2001.0949","article-title":"Clinical aspects and management of cytomegalovirus infection","volume":"44","author":"Sissons","year":"2002","journal-title":"J Infect"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0250","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.coi.2007.07.012","article-title":"Acceleration of allograft failure by cytomegalovirus","volume":"19","author":"Streblow","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0255","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1001\/archderm.1980.01640340084023","article-title":"Vasculitis in cytomegalovirus infection","volume":"116","author":"Weigand","year":"1980","journal-title":"Arch Dermatol"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0260","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00000372-198206000-00016","article-title":"Cytomegalovirus infection of the skin","volume":"4","author":"Walker","year":"1982","journal-title":"Am J Dermatopathol"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0265","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0190-9622(84)70234-9","article-title":"Vesiculobullous lesions caused by cytomegalovirus infection in an immunocompromised adult","volume":"11","author":"Bhawan","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0270","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0190-9622(89)70254-1","article-title":"Clinically occult cytomegalovirus present in skin biopsy specimens in immunosuppressed hosts","volume":"21","author":"Horn","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0275","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0190-9622(83)70212-4","article-title":"Histologically specific skin lesions in disseminated cytomegalovirus infection","volume":"9","author":"Pariser","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0280","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0190-9622(88)70143-7","article-title":"Cytomegalovirus infections and the skin","volume":"18","author":"Lesher","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0285","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1076\/ocii.7.3.215.4010","article-title":"Immune recovery uveitis","volume":"7","author":"Holland","year":"1999","journal-title":"Ocular Immunol Inflamm"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0290","first-page":"452","article-title":"Severe cutaneous ulceration secondary to cytomegalovirus inclusion disease during successful immune reconstitution with HAART","volume":"12","author":"Qazi","year":"2002","journal-title":"AIDS Read"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0295","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/archdermatol.2009.195","article-title":"Cytomegarovirus disease during the course of severe drug eruptions: report of two cases and retrospective study of 18 patients with drug-induced hypersensitivity syndrome","volume":"145","author":"Asano","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0300","first-page":"443","article-title":"Mucocutaneous presence of cytomegalovirus associated with human immunodeficiency virus infection: discussion regarding its pathogenetic role","volume":"137","author":"Daud\u00e9n","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0305","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s11904-009-0022-z","article-title":"Management of patients with the immune reconstitution inflammatory syndrome","volume":"6","author":"Marais","year":"2009","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0310","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.autrev.2009.02.029","article-title":"Viral connection between drug rashes and autoimmune diseases: how autoimmune responses are generated after resolution of drug rashes","volume":"8","author":"Aota","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0315","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000187619","article-title":"Systemic lupus erythematous presenting with Kikuchi-Fujimoto\u2019s disease as a long-term sequela of drug-induced hypersensitivity syndrome. A possible role of Epstein-Barr virus reactivation","volume":"218","author":"Aota","year":"2009","journal-title":"Dermatology"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0320","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/j.jinf.2005.10.011","article-title":"Immune re-constitution syndrome associated with parvovirus B19-induced pure red cell aplasia during highly active antiretroviral therapy","volume":"53","author":"Intalapaporn","year":"2006","journal-title":"J Infect"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0325","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1086\/427941","article-title":"Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis","volume":"40","author":"Garcia Vidal","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0330","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1086\/522993","article-title":"A patient with de nove tuberculosis during antitumor necrosis factor-alpha therapy illustrating diagnostic pitfalls and paradoxical response to treatment","volume":"45","author":"Arend","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0335","first-page":"1057","article-title":"Immune reconstitution by Mycobacterium tuberculosis after discontinuing infliximab","volume":"9","author":"Belknap","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0340","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0190-9622(99)70364-6","article-title":"Sarcoidosis in a patient with AIDS: a manifestation of immune restoration syndrome","volume":"41","author":"Mirmirani","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.2332\/allergolint.10-RAI-0260_bb0345","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.imlet.2003.11.023","article-title":"T cell contributions to the different phases of granuloma formation","volume":"92","author":"Co","year":"2004","journal-title":"Immunol Lett"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1323893015306444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1323893015306444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T21:45:14Z","timestamp":1559857514000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893015306444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"alternative-id":["S1323893015306444"],"URL":"https:\/\/doi.org\/10.2332\/allergolint.10-rai-0260","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}